Measuring NaGalase Levels to Assess Tumor Response to Treatments
Author Information
Author(s): M Korbelik, VR Naraparaju, N Yamamoto
Primary Institution: British Columbia Cancer Agency; Albert Einstein Cancer Center
Hypothesis
How does the serum NaGalase activity reflect the response of tumors to radiotherapy and photodynamic therapy?
Conclusion
Serum NaGalase levels can effectively indicate tumor response to different cancer treatments.
Supporting Evidence
- NaGalase levels increased with tumor growth and decreased after effective treatment.
- Serum NaGalase activity was directly proportional to tumor burden.
- Elevated NaGalase levels predicted tumor regrowth before visible recurrence.
Takeaway
This study shows that measuring a specific enzyme in the blood can help doctors understand how well cancer treatments are working.
Methodology
Mice with SCCVII tumors were treated with X-rays or photodynamic therapy, and serum NaGalase levels were measured over time.
Limitations
The study was conducted on mice, which may not fully represent human responses.
Participant Demographics
8- to 11-week-old female mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website